
Sign up to save your podcasts
Or


Send us a text
We return to discuss stereotactic radiotherapy (SABR) in prostate cancer with the superb Dr Alison Tree from The Royal Marsden Hospital.
We discuss the findings of the TRAP study which extended time to next treatment by 6 months when SABR was used for sites of growing disease.
Do we always need to change systemic therapy when only one or two sites of metastatic disease is growing??
By John McGrane & Michael RoweSend us a text
We return to discuss stereotactic radiotherapy (SABR) in prostate cancer with the superb Dr Alison Tree from The Royal Marsden Hospital.
We discuss the findings of the TRAP study which extended time to next treatment by 6 months when SABR was used for sites of growing disease.
Do we always need to change systemic therapy when only one or two sites of metastatic disease is growing??